Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease

Angelo Antonini^{1

2}, Aron Emmi^{2

3}, Marta Campagnolo¹

Affiliations

¹ Parkinson and Movement Disorders Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience University of Padova Padova Italy.
² Center for Neurodegenerative Diseases (CESNE) University of Padova Padova Italy.
³ Institute of Human Anatomy, Department of Neuroscience University of Padova Padova Italy.

Angelo Antonini et al. Mov Disord Clin Pract. 2023.

. 2023 Jun 1;10(Suppl 2):S50-S55.

doi: 10.1002/mdc3.13786. eCollection 2023 Aug.

Angelo Antonini^{1

2}, Aron Emmi^{2

3}, Marta Campagnolo¹

¹ Parkinson and Movement Disorders Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience University of Padova Padova Italy.
² Center for Neurodegenerative Diseases (CESNE) University of Padova Padova Italy.
³ Institute of Human Anatomy, Department of Neuroscience University of Padova Padova Italy.

No abstract available

Keywords: Parkinson; l‐dopa; motor complications; progression.

Figures

1. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283–2301. - PubMed
1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002;14(2):222–236. - PubMed
1. Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, Postuma RB. Prodromal Parkinson disease subtypes‐key to understanding heterogeneity. Nat Rev Neurol 2021;17:349–361. - PubMed
1. Hely MA, Morris JG, Reid WG, et al. Sydney multicenter study of Parkinson's disease: non‐ l‐dopa responsive problems dominate at 15 years. Mov Disord 2015;20:190–199. - PubMed
1. Chaudhuri KR, Odin P, Antonini A, Martinez‐Martin P. Parkinson's disease: the non‐motor issues. Parkinsonism Relat Disord 2011;17(10):717–723. - PubMed